Sun Pharma Canada Inc. Ranitidine Product Recall (2019-10-29)
- Starting date:
- October 29, 2019
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-71495
Last updated: 2019-10-30
A. RAN-Ranitidine 150mg
B. RAN-Ranitidine 300mg
Reason
Affected lots may be manufactured with an API containing an impurity, N-nitrosodimethylamine (NDMA)
Depth of distribution
Wholesalers, Healthcare Establishments, Retailers
Affected products
A. RAN-Ranitidine 150mg
DIN, NPN, DIN-HIM
DIN 02336480
Dosage form
Tablet
Strength
Ranitidine hydrochloride 150mg
Lot or serial number
7703396A, 7703396B
Companies
- Recalling Firm
-
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
- Marketing Authorization Holder
-
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
B. RAN-Ranitidine 300mg
DIN, NPN, DIN-HIM
DIN 02336502
Dosage form
Tablet
Strength
Ranitidine hydrochloride 300mg
Lot or serial number
7703365A, 7702668A
Companies
- Recalling Firm
-
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
- Marketing Authorization Holder
-
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA